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INTRODUCTION: Neuroblastoma is the most common extracranial solid pediatric malignancy. The most
common site is abdomenwith predominance of suprarenalmedulla. Inﬁltration of the tumour to the liver
is rare. No caseswere reported in the literature about themisdiagnosis of neuroblastomaasmesenchymal
hamartoma in the liver.
PRESENTATION OF CASE: We represent a rare case of neuroblastoma misdiagnosed as mesenchymal
hamartoma in liver in a six-month-old female infant presentedwith fever and abdominal mass. Abdomi-
nal computed tomography (CT) revealed large cystic lesionoccupyingmost of the right liver enchroaching
upon right suprarenal region and displacing the right kidney inferior suggestive formesenchymal hamar-
toma. Right adrenalectomywith en-bloc resection of the adjacent liver segmentswas done. Postoperative
pathology revealed neuroblastoma with positive speciﬁc immunohistochemistry (IHC).
DISCUSSION: Although neuroblastoma is the secondmost common pediatric abdominal malignancywith
speciﬁc diagnostic modalities, a misdiagnosis of a case with neuroblastoma asmesenchymal hamartoma
is rare. Histopathological diagnosis of neuroblastoma with positive IHC is essential as shown in our case.
CONCLUSION: We represent a rare case of neuroblastoma which arose from the right adrenal gland and
inﬁltrated the adjacent liver substancemimickingmesenchymal hamartoma of the liver. Neuroblastoma
is rarely presented with pyrexia of unknown origin. Neuroblastoma should be considered in differential
diagnosis of abdominal mass in all infants and children.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Neuroblastoma (NB) is the most common extracranial solid
pediatric malignancy representing 8–10% of all childhood malig-
nancies. It is an embryonal tumor which originates from the
sympathetic nervous system [1]. NB has been described as an
extremely heterogeneous because of its highly variable biologic
behavior [2], ranging from spontaneous regression to a progres-
sive course with fatal outcome [1,3]. About 90% of patients are
diagnosed with neuroblastoma before the age of 5 years (median
age at diagnosis of 18 months) [4]. Nearly 65% of tumours arise
in the abdomen and they are usually localized to the medulla
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of the adrenal gland [5]. Most patients are symptoms-free, but
some may present with constitutional symptoms (malaise, fever,
and weight loss), an enlarging mass, pain, abdominal distention,
lymphadenopathy, or respiratory embarrassment secondary to
compression or hepatomegaly [6]. Biochemical diagnostic ﬁnd-
ings include increased levels of serum or urine catecholamines
or its metabolites and/or nonspeciﬁc biomarkers such as lactate
dehydrogenas, ferritin, and neuron-speciﬁc enolase that may be
associated with advanced stage or prolapse [7]. For diagnostic
imaging, computed tomography (CT) scan and/or magnetic res-
onance imaging (MRI) are the gold standard for detection of the
tumour site, size and degree of involvement [8]. Histopathological
examination with speciﬁc immunohistochemistry is essential for
ﬁnal diagnosis. The standard lines of treatment in management of
neuroblastoma include chemotherapy, radiotherapy and/or surgi-
cal resection [9]. Neuroblastoma arising from suprarenal medulla
inﬁltrating the right liver with radiological ﬁnding suggestive for
mesenchymal hamartoma is rare. We report a case of neurob-
lastoma inﬁtrating the right liver misdiagnosed as mesenchymal
hamartoma.
http://dx.doi.org/10.1016/j.ijscr.2015.05.024
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. CT abdomen shows large well deﬁned, non-enhanced hypodense cystic lesion occupying most of the right liver lobe (segment V,VI,VII) measuring (8×8×8.3 cm)
with exophytic component enchroaching upon right suprarenal region and displacing the right kidney inferior suggestive for mesencymalhamartoma.
1.1. Presentation of case
A six-month-old female infant was referred to our center by
right liver mass mostly mesenchymal hamartoma on radiological
basis for surgical intervention. She was admitted in children hos-
pital for pyrexia of unknown origin with no response to antibiotics
and antipyretics. Fever was associated with right hypochon-
drial pain and abdominal enlargement without jaundice for one
month. Perinatal history was uneventful. On examination, there
was right hypochondrial tenderness and hepatomegaly with liver
span equals 8 cm (normal liver span for this age is 5–5.5 cm).
Laboratory investigations showed microcytic hypochromic ane-
mia (Haemoglobin =8.4 gm/dl), leukocytosis (White blood cells’
count =13.1×103), thrombocytosis (Platelets =620×103), slightly
elevated alpha-feto protein (AFP) (AFP=26.6ng/ml) and normal
liver function tests (LFTs).Abdominalultrasonography (US) showed
well-deﬁnedheterogeneousmasswith cysticdegenerationand foci
of calciﬁcation affecting most of the right liver measuring about
7.4×8.4 cm. Abdominal computed tomography (CT) with contrast
showed large well deﬁned, non-enhanced hypodense cystic lesion
occupying most of the the right liver (segment V,VI,VII) measur-
ing (8×8×8.3 cm) with exophytic component enchroaching upon
right suprarenal region and displacing the right kidney inferiorly
with no enlarged abdominal lymph node (LN). Themasswas highly
suggestive for the right liver mesenchymal hamartoma as shown
in (Fig. 1). No liver biopsywas taken. The provisional diagnosis was
mesenchymal hamartoma or hepatoblastoma for surgical resec-
tion and histopathological conﬁrmation. The mother of the infant
underwent informed written consent for surgery.
On exploration, there were no signs of peritoneal seeding or
involvement of adjacent organs. The liver was completely healthy
with largemassmainly in segmentVI andVII adherent to transverse
colon with displacement of the right kidney downward. After sur-
gical assessment of the tumor, Right adrenalectomy with en-bloc
resection of the adjacent liver segmentswas performedwith safety
margin about 1 cm of liver tissue after dissection of the mass from
the right renal vessels. No residual tumour tissue was left (R0).
1.2. Postoperative pathology
Grossly the mass was friable measuring about 9×8×8 cm. Cut
section revealed large areas of hemorrhage and necrosis with inﬁl-
tration of adjacent liver tissue. Microscopically the tumor cells are
small with hyperchromatic nuclei and scanty cytoplasm, and are
arranged in sheets separated by thin ﬁbro-vascular septa between
the nests of tumor cells . Few ganglion cells 9.5% of tumor popu-
lation are detected. There are wide areas of necrosis. No evidence
of HomerWright rosettes or pseudorosettes was detected. Surgical
margins were free from tumor inﬁltration as shown in Figs. 2–5.
Postoperative course was uneventful and the patient was dis-
charged after 6 days in good general condition. The patient was
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Fig. 2. The tumor is formed of small cells separated by ﬁbro-vascular septa (H&E
staining 100×).
Fig. 3. Malignant small cellswith ganglion cell differentiation (arrow) (H&E staining
400×).
Fig. 4. Positive membranous reaction of CD56 immunohistochemistry (400×).
Fig. 5. Positive cytoplasmic reaction of chromogranin A immunohistochemistry
(400×).
Fig. 6. Negative reaction of HepPar-1 immunohistochemistry (400×).
referred to pediatric oncology department for receiving adjuvant
chemotherapy in the form of cisplatin and adriamycin Fig. 6.
1.3. Discussion
Neuroblastoma is themost common extracranial solid pediatric
malignancy representing 8-10% of all childhood malignancies. It is
an embryonal tumor arises from the sympathetic nervous system.
It accounts for approximately 15% of all cancer-related deaths in
the pediatric population [1]. Neuroblastoma has been described as
an extremely heterogeneous because of its highly variable biologic
behavior [10], ranging from spontaneously regression to a pro-
gressive course with ultimate fatal outcome [1,3]. Our case was
six-month-old infant at the time of diagnosis which is a com-
mon age for diagnosis of neuroblastoma as reported in literature
[4]. More than 50% of patients with neuroblastoma are diagnosed
as high-risk neuroblastoma with features including large unre-
sectable and widely metastatic tumour resulting in poor prognosis
as regard long-termsurvival [11].Nearly65%of tumours arise in the
abdomen with half of those localized to the medulla of the adrenal
gland [12] as reported in our case. In our report, the girl presented
by fever of unknown origin for 2 weeks followed by abdominal
enlargement and pain as reported in previous studies [6]. Biochem-
ical diagnostic tests of neuroblastoma include serum or urinary
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level of catecholamines or its metabolites (dopamine, vanillylman-
delic acid, and homovanillic acid) and/or nonspeciﬁc biomarkers
such as lactate dehydrogenase, ferritin, and neuron-speciﬁc eno-
lase [7]. None of these laboratory tests were done preoperatively
because the liver mass was not suspicious of neuroblastoma on
radiological basis. For diagnostic imaging, abdominal CT scan of
the abdomen is the gold standard for detection of the tumour site
and the degree of involvement. A magnetic resonance imaging is
more sensitive in cases of spinal extention [8]. In our case, the
abdominal CT revealed large cystic lesion in the right liver just dis-
placing the right kidney and the right suprarenal gland and it was
highly suggestive formesenchymal hamartomawhich is classic for
it as reported in the literature [13], while radiologic ﬁndings of
neuroblastoma include focal or multifocal solid tumor with calciﬁ-
cation in 40%–50% of cases,which is not essential for diagnosis [14].
Other diagnostic tests include, but not done in our case, iodine-131-
meta-iodobenzylguanidine (MIBG) which is useful in detection of
both primary tumour and metastasis but not widely used in clini-
cal practice and ﬂurodeoxyglucose positron emission tomography
(FDG-PET) which maybe valuable in localizing soft tissue metasta-
sis [15]. Conﬁrmation of the diagnosis is conﬁrmed pathologically
by tissue biopsy either by complete resection or open biopsy in
case of unresectable tumours and/or BM aspiration [16]. No preop-
erative US or CT guided biopsy from the mass was done to avoid
dissemination and seeding of the tumour cells as hepatoblastoma
was considered in the differential diagnosis of our case.
The standard lines of treatment in management of neu-
roblastoma include chemotherapy, radiotherapy and/or surgical
resection. Many new promising therapies were introduced based
onmolecularmechanisms for differentiation, cell survival and apo-
ptosis [17]. The surgical resection offers deﬁnitive therapy with
excellent outcome for management of locoregional low-risk neu-
roblastoma [18],while high-risk patients are treatedwith intensive
multimodality therapies. In our case, the decision was surgical
resection from the start if the tumour was resectable for ﬁnal
pathological diagnosis as the provisional diagnosis was whether
hepatoblastoma or mesenchymal hamartoma.
2. Conclusion
We represent a rare case of right adrenal gland neuroblastoma
inﬁltrated the adjacent liver segments mimicking mesenchymal
hamartoma of the liver. Neuroblatoma is rarely presented with
pyrexia of unknownorigin. Neuroblastoma should be considered in
differential diagnosis of abdominalmass in all infants and children.
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